(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Cynthia Koons \u0010Health Care Reporter \u0010Bloomberg Editorial \u0010on Pfizer beating out rivals to buy biopharmaceutical company, Medivation, and its blockbuster cancer drug for $14 billion.

AI Fears Mount on CEO Calls for Slowdown
22:26

OpenAI Says It’s Working With Anthropic, Google on AI Safety
07:54

AI Bosses Risk Clash With Wall Street and Trump Over Safety
21:45